• Jump to content
  • Jump to navigation
  • Jump to search
Bionor Pharma 2012
Search
  • Home
  • Vaccines & technology
  • News
  • Investors
  • About Bionor Pharma
  • Contact us
  • Sitemap
  • You are here:
    1. Frontpage
    2. Vaccines & technology
    3. Scientific Advisory Board
    4. Kristian Prydz, PhD
  • Platform technology
  • HIV vaccine Vacc-4x
  • HIV vaccine Vacc-C5
  • Pipeline
  • Hepatitis C (HCV)
  • Influenza
  • Other Indications
  • History
  • Publications
  • Clinical Advisory Board
  • Scientific Advisory Board
  • Brochure

Latest News Full archive ››

  • Annual General Meeting Strengthens the Board of Directors with Financial and Regulatory CompetenciesFinancial 15.05.2013
  • Invitation to Annual General Meeting 15 May 2013Financial 24.04.2013

CalendarFull calendar ››

  • Feb 15Financial calendar 2013 for Bionor Pharma ASA

E-mail alert More info ››

      • Home
      • Vaccines & technology
      • News
      • Investors
      • About Bionor Pharma
      • Contact us
      • Sitemap

    • Bionor Pharma ASA Kronprinsesse Märthas Plass 1 P.O. Box 1477 Vika, NO-0116 Oslo, Norway, Tel.: +47 23 01 09 60, Fax +47 23 01 09 70 

      Site by Pinpoint & Idium